Tomino Y - Search Results

1

Beneficial effects of combination therapy with olmesartan and azelnidipine in murine polycystic kidneys.

Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Takahashi H, Tomino Y. Tanifuji C, et al. Among authors: tomino y. Kidney Blood Press Res. 2009;32(4):239-49. doi: 10.1159/000238821. Epub 2009 Sep 14. Kidney Blood Press Res. 2009. PMID: 19752573

2

Mindin: a novel marker for podocyte injury in diabetic nephropathy.

Murakoshi M, Tanimoto M, Gohda T, Hagiwara S, Takagi M, Horikoshi S, Tomino Y. Murakoshi M, et al. Among authors: tomino y. Nephrol Dial Transplant. 2011 Jul;26(7):2153-60. doi: 10.1093/ndt/gfq708. Epub 2010 Nov 22. Nephrol Dial Transplant. 2011. PMID: 21098016

3

IgA nephropathy: lessons from an animal model, the ddY mouse.

Tomino Y. Tomino Y. J Nephrol. 2008 Jul-Aug;21(4):463-7. J Nephrol. 2008. PMID: 18651534 Review.

4

Pathogenesis of IgA nephropathy.

Tomino Y. Tomino Y. Contrib Nephrol. 2007;157:1-7. doi: 10.1159/000102280. Contrib Nephrol. 2007. PMID: 17495430 Review.

5

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.

Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Ueda H, Moldoveanu Z, Kiryluk K, Suzuki Y, Wyatt RJ, Tomino Y, Gharavi AG, Weinmann A, Julian BA, Willey CD, Novak J. Yamada K, et al. Among authors: tomino y. Kidney Int Rep. 2017 Jul 19;2(6):1194-1207. doi: 10.1016/j.ekir.2017.07.002. eCollection 2017 Nov. Kidney Int Rep. 2017. PMID: 29270528 Free PMC article.

6

Diagnosis and treatment of patients with IgA nephropathy in Japan.

Tomino Y. Tomino Y. Kidney Res Clin Pract. 2016 Dec;35(4):197-203. doi: 10.1016/j.krcp.2016.09.001. Epub 2016 Sep 15. Kidney Res Clin Pract. 2016. PMID: 27957413 Free PMC article. Review.

7

Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.

Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y. Sonoda Y, et al. Among authors: tomino y. PLoS One. 2015 Apr 10;10(4):e0122212. doi: 10.1371/journal.pone.0122212. eCollection 2015. PLoS One. 2015. PMID: 25860248 Free PMC article.

8

Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients.

Io H, Ro Y, Sekiguchi Y, Shimaoka T, Inuma J, Hotta Y, Aruga S, Inami Y, Sato M, Kobayashi T, Masuda A, Kaneko K, Hamada C, Ohtaki E, Horikoshi S, Tomino Y. Io H, et al. Among authors: tomino y. Perit Dial Int. 2010 May-Jun;30(3):353-61. doi: 10.3747/pdi.2009.00007. Epub 2010 Mar 25. Perit Dial Int. 2010. PMID: 20338970

9

Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.

Tanimoto M, Gohda T, Kaneko S, Hagiwara S, Murakoshi M, Aoki T, Yamada K, Ito T, Matsumoto M, Horikoshi S, Tomino Y. Tanimoto M, et al. Among authors: tomino y. Metabolism. 2007 Feb;56(2):160-7. doi: 10.1016/j.metabol.2006.08.026. Metabolism. 2007. PMID: 17224327

10

Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients.

Masuda A, Hagiwara S, Tanimoto M, Kodama F, Okumura K, Nohara N, Matsumoto M, Maiguma M, Omote K, Io H, Kurusu A, Ohsawa I, Shimizu Y, Hamada C, Horikoshi S, Tomino Y. Masuda A, et al. Among authors: tomino y. Nephron Extra. 2012 Sep 27;2(1):256-68. doi: 10.1159/000342258. Print 2012 Jan. Nephron Extra. 2012. PMID: 23599704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results